- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- NAG.5: 3 residues within 4Å:- Chain A: E.257, V.258, N.261
 3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:E.257, A:V.258
- Hydrogen bonds: A:N.261
 - NAG.6: 2 residues within 4Å:- Chain A: N.287, T.289
 2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.287, A:T.289
 - NAG.7: 3 residues within 4Å:- Chain A: N.468, Q.476, T.478
 1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.478
 - NAG.19: 2 residues within 4Å:- Chain B: V.258, N.261
 2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:V.258
- Hydrogen bonds: B:N.261
 - NAG.20: 2 residues within 4Å:- Chain B: N.287, T.289
 1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.287
 - NAG.21: 3 residues within 4Å:- Chain B: N.468, Q.476, T.478
 2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.478
- Hydrogen bonds: B:N.468
 
- 2 x TCR: CYCLOMETHYLTRYPTOPHAN(Non-covalent)
- TCR.8: 11 residues within 4Å:- Chain A: R.66, W.70, T.145, G.146, S.147, A.168, S.169, S.170, Y.218, E.297, A.298
 7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.70, A:T.145, A:A.298
- Hydrogen bonds: A:S.147, A:A.168, A:S.170, A:E.297
 - TCR.22: 11 residues within 4Å:- Chain B: R.66, W.70, T.145, G.146, S.147, A.168, S.169, S.170, Y.218, E.297, A.298
 7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.70, B:T.145, B:A.298
- Hydrogen bonds: B:S.147, B:A.168, B:S.170, B:E.297
 
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- PO4.9: 8 residues within 4Å:- Chain A: R.66, R.69, W.70, H.413, L.414, R.415, I.416, S.417
 8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:W.70, A:H.413, A:H.413, A:R.415, A:I.416, A:S.417
- Salt bridges: A:R.66, A:R.69
 - PO4.23: 8 residues within 4Å:- Chain B: R.66, R.69, W.70, H.413, L.414, R.415, I.416, S.417
 8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:W.70, B:H.413, B:H.413, B:R.415, B:I.416, B:S.417
- Salt bridges: B:R.66, B:R.69
 
- 8 x CA: CALCIUM ION(Non-covalent)
- CA.10: 5 residues within 4Å:- Chain A: I.81, N.82, S.84, L.87, L.88
 3 PLIP interactions:3 interactions with chain A- Metal complexes: A:I.81, A:S.84, A:L.87
 - CA.11: 7 residues within 4Å:- Chain A: L.37, F.38, P.39, T.100, A.144, T.145, Y.167
 1 PLIP interactions:1 interactions with chain A- Metal complexes: A:T.100
 - CA.12: 3 residues within 4Å:- Chain A: F.42, G.273, S.302
 1 PLIP interactions:1 interactions with chain A- Metal complexes: A:S.302
 - CA.13: 2 residues within 4Å:- Chain A: G.557
- Chain B: D.234
 1 PLIP interactions:1 interactions with chain A- Metal complexes: A:G.557
 - CA.24: 5 residues within 4Å:- Chain B: I.81, N.82, S.84, L.87, L.88
 3 PLIP interactions:3 interactions with chain B- Metal complexes: B:I.81, B:S.84, B:L.87
 - CA.25: 7 residues within 4Å:- Chain B: L.37, F.38, P.39, T.100, A.144, T.145, Y.167
 1 PLIP interactions:1 interactions with chain B- Metal complexes: B:T.100
 - CA.26: 3 residues within 4Å:- Chain B: F.42, G.273, S.302
 1 PLIP interactions:1 interactions with chain B- Metal complexes: B:S.302
 - CA.27: 3 residues within 4Å:- Chain B: G.557, E.558, P.559
 1 PLIP interactions:1 interactions with chain B- Metal complexes: B:G.557
 
- 2 x 9IG: 3-(2-chlorophenyl)-N-[(1R)-1-(3-methoxyphenyl)ethyl]propan-1-amine(Non-covalent)
- 9IG.14: 10 residues within 4Å:- Chain A: F.668, Q.681, F.684, G.685, L.773, L.776, I.777, T.780, W.818, E.837
 6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.668, A:F.684, A:L.776, A:W.818
- Hydrogen bonds: A:Q.681
- pi-Stacking: A:F.684
 - 9IG.28: 9 residues within 4Å:- Chain B: F.668, Q.681, F.684, L.773, L.776, I.777, T.780, W.818, E.837
 9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:F.668, B:F.684, B:L.776, B:I.777, B:I.777, B:W.818
- Hydrogen bonds: B:Q.681, B:Q.681
- pi-Stacking: B:F.684
 
- 8 x CLR: CHOLESTEROL(Non-covalent)
- CLR.15: 10 residues within 4Å:- Chain A: F.821, F.832, V.836, I.839, A.843
- Chain B: I.819, P.823, A.826
- Ligands: CLR.17, CLR.31
 7 PLIP interactions:4 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.821, A:F.832, A:V.836, A:A.843, B:I.819, B:P.823, B:P.823
 - CLR.16: 11 residues within 4Å:- Chain A: L.812, I.816, S.820
- Chain B: F.809, L.812, I.813, I.816, V.817
- Ligands: CLR.29, CLR.30, CLR.31
 8 PLIP interactions:6 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.809, B:L.812, B:I.813, B:I.813, B:I.816, B:V.817, A:L.812, A:I.816
 - CLR.17: 9 residues within 4Å:- Chain A: F.806, I.813, A.843, F.846, G.847, A.850, C.851
- Ligands: CLR.15, CLR.31
 4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:F.806, A:I.813, A:F.846, A:A.850
 - CLR.18: 6 residues within 4Å:- Chain A: C.781, A.785, F.788, F.789, F.792, I.819
 5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:A.785, A:F.788, A:F.788, A:I.819, A:I.819
 - CLR.29: 8 residues within 4Å:- Chain A: I.819, P.823, A.826
- Chain B: F.821, F.832, I.839
- Ligands: CLR.16, CLR.30
 6 PLIP interactions:3 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:I.819, A:P.823, A:P.823, B:F.821, B:F.832, B:I.839
 - CLR.30: 5 residues within 4Å:- Chain B: F.806, I.813, A.850
- Ligands: CLR.16, CLR.29
 4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:F.806, B:I.813, B:I.813, B:A.850
 - CLR.31: 11 residues within 4Å:- Chain A: F.809, L.812, I.813, I.816, V.817
- Chain B: L.812, I.816, S.820
- Ligands: CLR.15, CLR.16, CLR.17
 9 PLIP interactions:7 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.809, A:F.809, A:L.812, A:I.813, A:I.813, A:I.816, A:V.817, B:L.812, B:I.816
 - CLR.32: 6 residues within 4Å:- Chain B: C.781, A.785, F.788, F.789, F.792, I.819
 6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.785, B:F.788, B:F.788, B:F.789, B:I.819, B:I.819
 
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Park, J. et al., Symmetric activation and modulation of the human calcium-sensing receptor. Proc.Natl.Acad.Sci.USA (2021)
            
- Release Date
- 2022-01-19
- Peptides
- Isoform 1 of Extracellular calcium-sensing receptor: AB
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 B
- Membrane
- 
            We predict this structure to be a membrane protein. 
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x TCR: CYCLOMETHYLTRYPTOPHAN(Non-covalent)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- 8 x CA: CALCIUM ION(Non-covalent)
- 2 x 9IG: 3-(2-chlorophenyl)-N-[(1R)-1-(3-methoxyphenyl)ethyl]propan-1-amine(Non-covalent)
- 8 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Park, J. et al., Symmetric activation and modulation of the human calcium-sensing receptor. Proc.Natl.Acad.Sci.USA (2021)
            
- Release Date
- 2022-01-19
- Peptides
- Isoform 1 of Extracellular calcium-sensing receptor: AB
- SMTL:PDB
- SMTL Chain Id:
 PDB Chain Id:A
 AB
 B
- Membrane
- 
            We predict this structure to be a membrane protein.